Skip to main content
SpringerLink
Log in
Book cover

Controversies in the Management of Gynecological Cancers

  • Book
  • © 2014

Overview

Editors:
  1. Jonathan A. Ledermann

    1. UCL Cancer Institute, University College London, London, United Kingdom

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Carien L. Creutzberg

    1. Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. Michael A. Quinn

    1. Royal Women’s Hospital, The University of Melbourne, Melbourne, Australia

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • A didactic scientific discussion of controversial issues

  • International authorship including many key opinion leaders

  • Text is concise, with a comprehensive literature review, clearly illustrating different and opposing sides to the controversies, concluding with a section on the direction of future research to resolve these issues

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (29 chapters)

  1. Front Matter

    Pages i-xv
    Download chapter PDF

  2. Controversies in the Treatment of Women with Early-Stage Epithelial Ovarian Cancer

    • Christina Fotopoulou, Ann Marie Swart, Robert L. Coleman
    Pages 1-15

  3. Recurrent Ovarian Cancer: When to Treat and How to Assess

    • Rene Roux, Ignacio Romero, Martin Zweifel, Gordon Rustin, Robert C. Bast Jr.
    Pages 17-27

  4. New Views of Ovarian Carcinoma Types: How Will This Change Practice?

    • Martin Köbel, Robert J. Kurman, Jeffrey D. Seidman
    Pages 29-38

  5. Lymphadenectomy in Endometrial Cancer: The Controversy Rages Unabated

    • Henry C. Kitchener, Kristina A. Butler, Emma J. Crosbie, Andrea Mariani
    Pages 39-46

  6. What Is the Role of Adjuvant Radiotherapy and Chemotherapy in Endometrial Cancer?

    • Thomas Hogberg, Carien L. Creutzberg
    Pages 47-57

  7. Chemotherapy and/or Targeted Therapies for Advanced Endometrial Cancer: Time to Rethink?

    • Erica Stringer-Reasor, Gini Fleming, Daliah Tsoref, Amit Oza
    Pages 59-68

  8. Is Cervix Cancer a Disappearing Disease? Impact of HPV Vaccination in Developed Countries

    • Karen Canfell, Julietta Patnick
    Pages 69-77

  9. What Is the Role of Cytotoxic Chemotherapy in Advanced Cervical Cancer?

    • Alok Pant, Nobuyuki Susumu, Takafumi Toita, Satoru Sagae, William Small Jr.
    Pages 79-90

  10. Response as a Measure of Treatment Efficacy in Clinical Trials: Should RECIST Be Abandoned?

    • Michael Friedlander, James Tate Thigpen
    Pages 91-100

  11. What Are the Treatment Options for Recurrent Ovarian Cancer?

    • Jonathan A. Ledermann, Fharat A. Raja, Philipp Harter, Florian Heitz
    Pages 101-110

  12. How to Study Rare Gynecological Tumors: Trials or Registries?

    • Isabelle Ray-Coquard, David M. Gershenson
    Pages 111-119

  13. What Is the Best Treatment Model for Gynecologic Cancers? Does Centralization Help?

    • Claes Göran TropĂ©, Torbjørn Paulsen, Ayesha Saqib, Craig Underhill
    Pages 121-133

  14. When Should Surgery Be Performed for the First-Line Treatment of Advanced Ovarian Cancer?

    • Ganendra Raj K. A. Mohan, Jane Hook, Jonathan A. Ledermann, Michael A. Quinn
    Pages 135-143

  15. Does Intraperitoneal Therapy for Ovarian Cancer Have a Future?

    • Deborah K. Armstrong, Michael A. Bookman
    Pages 145-153

  16. Maintenance Therapy for First-Line Treatment of Ovarian Cancer: Is This the Strategy for the Future?

    • Nicoletta Colombo, Lucas Minig, Robert Burger
    Pages 155-163

  17. What Is the Value of Lymphadenectomy in Early Ovarian Cancer?

    • Sven Mahner, Jacobus Pfisterer, Ganendra Raj K. Ali Mohan, Michael A. Quinn
    Pages 165-173

  18. Sentinel Node Biopsy—Does It Help in the Management of Vulvar Cancer?

    • Maaike H. M. Oonk, Ate G. J. van der Zee, Paul Speiser
    Pages 175-183

  19. Controversies in the Management of Advanced Vulvar Cancer

    • Ericka Wiebe, Jacobus van der Velden, Gillian Thomas
    Pages 185-196

  20. Bowel Obstruction in Ovarian Cancer: To Operate or Not?

    • Ram Eitan, Alexander de Graeff, Dennis S. Chi
    Pages 197-202
Back to top

Keywords

About this book

This is a novel text that highlights the controversial areas in the management of gynecological cancers. None of the topics in this book have definitive answers; they represent the everyday decision-making facing gynecologists, oncologists, radiologists, pathologists and other health professionals treating women with these conditions. This book is not to be used as a traditional textbook; it is a text that specialists and trainees will use to help them weigh up the arguments that exist in a variety of areas in the treatment of gynecological cancers. Each chapter will have two or more authors, selected either for their opposing views or for their ability to provide an opposite view or opinion to the other. The content will be evidence-based, illustrating contrasting evidence and scientific opinion in the literature. Each chapter will close on a summary indicating the direction of research needed to address the issues being discussed.

Reviews

From the book reviews:

“This book tackles current issues in the field of gynecological cancer. … The book is geared towards specialists in the field, although residents may find it useful. … The material is current and the data well done. This would be a good book for motivated trainees to bring to the table for discussions with attendings. Overall, the authors do a good job.” (Anthony Shanks, Doody’s Book Reviews, November, 2014)

Editors and Affiliations

  • UCL Cancer Institute, University College London, London, United Kingdom

    Jonathan A. Ledermann

  • Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands

    Carien L. Creutzberg

  • Royal Women’s Hospital, The University of Melbourne, Melbourne, Australia

    Michael A. Quinn

Bibliographic Information

  • Book Title: Controversies in the Management of Gynecological Cancers

  • Editors: Jonathan A. Ledermann, Carien L. Creutzberg, Michael A. Quinn

  • DOI: https://doi.org/10.1007/978-0-85729-910-9

  • Publisher: Springer London

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer-Verlag London 2014

  • Hardcover ISBN: 978-0-85729-909-3Published: 08 January 2014

  • Softcover ISBN: 978-1-4471-7170-6Published: 23 August 2016

  • eBook ISBN: 978-0-85729-910-9Published: 13 December 2013

  • Edition Number: 1

  • Number of Pages: XV, 349

  • Number of Illustrations: 13 b/w illustrations, 31 illustrations in colour

  • Topics: Oncology, Gynecology, Surgical Oncology

Publish with us

Policies and ethics

Back to top

Search

Navigation